| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myeloproliferative Disorders | 56 | 2025 | 87 | 18.130 |
Why?
|
| Janus Kinase 2 | 60 | 2025 | 132 | 13.880 |
Why?
|
| Polycythemia Vera | 21 | 2025 | 39 | 5.300 |
Why?
|
| Hematopoietic Stem Cells | 24 | 2025 | 541 | 4.300 |
Why?
|
| Thrombocythemia, Essential | 15 | 2025 | 30 | 4.120 |
Why?
|
| Primary Myelofibrosis | 15 | 2025 | 51 | 4.060 |
Why?
|
| Thrombocytosis | 18 | 2015 | 34 | 3.760 |
Why?
|
| Mutation | 54 | 2025 | 5845 | 3.630 |
Why?
|
| Interferon-alpha | 3 | 2025 | 230 | 2.270 |
Why?
|
| Thrombopoietin | 18 | 2018 | 32 | 2.250 |
Why?
|
| Megakaryocytes | 10 | 2021 | 42 | 2.220 |
Why?
|
| Proto-Oncogene Proteins | 17 | 2019 | 547 | 2.170 |
Why?
|
| Hematologic Neoplasms | 8 | 2022 | 285 | 2.120 |
Why?
|
| Receptors, Thrombopoietin | 14 | 2023 | 31 | 1.560 |
Why?
|
| Polycythemia | 7 | 2025 | 43 | 1.520 |
Why?
|
| Mutation, Missense | 7 | 2020 | 875 | 1.450 |
Why?
|
| Hematopoiesis | 10 | 2024 | 216 | 1.440 |
Why?
|
| Thrombopoiesis | 5 | 2014 | 11 | 1.400 |
Why?
|
| Neoplasm Proteins | 9 | 2019 | 667 | 1.290 |
Why?
|
| Erythropoiesis | 3 | 2016 | 39 | 1.240 |
Why?
|
| Calreticulin | 9 | 2025 | 20 | 1.240 |
Why?
|
| Receptors, Cytokine | 10 | 2005 | 68 | 1.220 |
Why?
|
| Mice | 47 | 2025 | 17632 | 1.180 |
Why?
|
| Alleles | 10 | 2020 | 1614 | 1.160 |
Why?
|
| Point Mutation | 8 | 2021 | 348 | 1.160 |
Why?
|
| Amino Acid Substitution | 12 | 2020 | 399 | 1.050 |
Why?
|
| Animals | 58 | 2025 | 34234 | 1.010 |
Why?
|
| Interleukin-1beta | 3 | 2024 | 162 | 1.000 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 3 | 2024 | 138 | 0.980 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2025 | 23 | 0.950 |
Why?
|
| Bone Marrow Neoplasms | 3 | 2015 | 23 | 0.940 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 2006 | 211 | 0.920 |
Why?
|
| Erythropoietin | 5 | 2025 | 105 | 0.910 |
Why?
|
| Benzeneacetamides | 1 | 2024 | 8 | 0.910 |
Why?
|
| Glutaminase | 1 | 2024 | 16 | 0.890 |
Why?
|
| Signal Transduction | 16 | 2019 | 4534 | 0.870 |
Why?
|
| Mice, Transgenic | 18 | 2021 | 2397 | 0.840 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 3 | 2019 | 62 | 0.820 |
Why?
|
| Osteosclerosis | 1 | 2022 | 12 | 0.810 |
Why?
|
| Clone Cells | 6 | 2021 | 166 | 0.800 |
Why?
|
| Thrombocytopenia | 6 | 2014 | 226 | 0.730 |
Why?
|
| Humans | 105 | 2025 | 125195 | 0.730 |
Why?
|
| Leukemia, Myeloid, Acute | 6 | 2022 | 536 | 0.710 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 94 | 0.710 |
Why?
|
| Erythroid Cells | 1 | 2020 | 24 | 0.700 |
Why?
|
| Mice, Inbred C57BL | 19 | 2025 | 4404 | 0.700 |
Why?
|
| Disease Models, Animal | 9 | 2025 | 4395 | 0.690 |
Why?
|
| Bone Marrow Transplantation | 10 | 2024 | 575 | 0.680 |
Why?
|
| Pyrazoles | 4 | 2024 | 305 | 0.670 |
Why?
|
| Blood Platelets | 10 | 2014 | 327 | 0.660 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 723 | 0.660 |
Why?
|
| Loss of Heterozygosity | 5 | 2007 | 124 | 0.650 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 | 2013 | 97 | 0.630 |
Why?
|
| DNA-Binding Proteins | 6 | 2019 | 2048 | 0.630 |
Why?
|
| Exons | 8 | 2016 | 798 | 0.610 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2014 | 618 | 0.600 |
Why?
|
| Chromosomes, Human, X | 4 | 2007 | 157 | 0.590 |
Why?
|
| Pyrimidines | 6 | 2024 | 374 | 0.580 |
Why?
|
| Gene Deletion | 4 | 2018 | 789 | 0.570 |
Why?
|
| Hydroxyurea | 3 | 2013 | 82 | 0.560 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 106 | 0.550 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 180 | 0.550 |
Why?
|
| Anemia | 2 | 2014 | 339 | 0.540 |
Why?
|
| Bone Marrow | 7 | 2021 | 325 | 0.520 |
Why?
|
| Valine | 5 | 2015 | 115 | 0.510 |
Why?
|
| Germ-Line Mutation | 4 | 2019 | 333 | 0.490 |
Why?
|
| Phenylalanine | 4 | 2015 | 128 | 0.490 |
Why?
|
| Clonal Evolution | 2 | 2020 | 40 | 0.480 |
Why?
|
| Receptors, Erythropoietin | 6 | 2015 | 12 | 0.470 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2016 | 468 | 0.470 |
Why?
|
| Microsatellite Repeats | 4 | 2018 | 221 | 0.470 |
Why?
|
| Protein Biosynthesis | 6 | 2024 | 663 | 0.470 |
Why?
|
| Cell Lineage | 5 | 2014 | 345 | 0.460 |
Why?
|
| Neoplasms | 4 | 2022 | 2790 | 0.450 |
Why?
|
| Mice, Knockout | 10 | 2022 | 3744 | 0.450 |
Why?
|
| Female | 50 | 2025 | 66807 | 0.450 |
Why?
|
| Stem Cell Niche | 3 | 2021 | 55 | 0.440 |
Why?
|
| STAT1 Transcription Factor | 1 | 2014 | 73 | 0.430 |
Why?
|
| STAT3 Transcription Factor | 2 | 2015 | 221 | 0.430 |
Why?
|
| Pedigree | 10 | 2025 | 1606 | 0.430 |
Why?
|
| Gene Expression Regulation | 5 | 2005 | 2522 | 0.420 |
Why?
|
| Granulocytes | 6 | 2016 | 65 | 0.420 |
Why?
|
| Male | 47 | 2025 | 61526 | 0.420 |
Why?
|
| Polyethylene Glycols | 2 | 2025 | 229 | 0.420 |
Why?
|
| Leukemia | 3 | 2019 | 372 | 0.410 |
Why?
|
| DNA Mutational Analysis | 8 | 2020 | 794 | 0.410 |
Why?
|
| Phenotype | 12 | 2023 | 4262 | 0.410 |
Why?
|
| Platelet Factor 4 | 2 | 2017 | 22 | 0.400 |
Why?
|
| Transgenes | 4 | 2014 | 336 | 0.400 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2016 | 138 | 0.400 |
Why?
|
| Philadelphia Chromosome | 3 | 2009 | 41 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2008 | 31 | 0.370 |
Why?
|
| Hematology | 2 | 2012 | 38 | 0.370 |
Why?
|
| Receptors, Cell Surface | 5 | 2005 | 470 | 0.350 |
Why?
|
| Promoter Regions, Genetic | 5 | 2012 | 1328 | 0.350 |
Why?
|
| RNA, Messenger | 10 | 2018 | 2820 | 0.350 |
Why?
|
| Chromosome Aberrations | 4 | 2007 | 613 | 0.340 |
Why?
|
| Aged, 80 and over | 14 | 2020 | 6598 | 0.330 |
Why?
|
| Middle Aged | 26 | 2025 | 26928 | 0.330 |
Why?
|
| Aged | 20 | 2025 | 19871 | 0.320 |
Why?
|
| Founder Effect | 1 | 2009 | 32 | 0.320 |
Why?
|
| Nitriles | 3 | 2022 | 146 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 3157 | 0.300 |
Why?
|
| Chromosome Deletion | 2 | 2008 | 647 | 0.300 |
Why?
|
| Thrombosis | 6 | 2025 | 526 | 0.300 |
Why?
|
| Adult | 26 | 2025 | 29628 | 0.300 |
Why?
|
| Anemia, Refractory | 1 | 2008 | 7 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 1893 | 0.290 |
Why?
|
| Anemia, Sideroblastic | 1 | 2008 | 17 | 0.290 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2024 | 541 | 0.280 |
Why?
|
| Iron | 2 | 2023 | 270 | 0.280 |
Why?
|
| Base Sequence | 10 | 2016 | 3103 | 0.280 |
Why?
|
| Intestinal Polyposis | 1 | 2007 | 17 | 0.280 |
Why?
|
| Mutant Proteins | 1 | 2007 | 114 | 0.280 |
Why?
|
| Smad4 Protein | 1 | 2007 | 57 | 0.270 |
Why?
|
| STAT5 Transcription Factor | 3 | 2018 | 88 | 0.270 |
Why?
|
| Molecular Sequence Data | 12 | 2007 | 3892 | 0.270 |
Why?
|
| Cell Differentiation | 6 | 2024 | 1898 | 0.270 |
Why?
|
| Leukemia, Myeloid | 1 | 2007 | 85 | 0.270 |
Why?
|
| Gene Silencing | 2 | 2005 | 236 | 0.270 |
Why?
|
| Thiazoles | 2 | 2018 | 98 | 0.250 |
Why?
|
| Carrier Proteins | 4 | 2005 | 1022 | 0.250 |
Why?
|
| Adolescent | 15 | 2025 | 19362 | 0.240 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2007 | 227 | 0.240 |
Why?
|
| Cytosol | 2 | 2024 | 162 | 0.240 |
Why?
|
| Flow Cytometry | 4 | 2014 | 797 | 0.230 |
Why?
|
| Homozygote | 5 | 2023 | 547 | 0.230 |
Why?
|
| Antigens, CD34 | 3 | 2021 | 109 | 0.230 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2024 | 58 | 0.230 |
Why?
|
| Cell Self Renewal | 1 | 2024 | 43 | 0.220 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 663 | 0.220 |
Why?
|
| Lentivirus | 1 | 2004 | 82 | 0.220 |
Why?
|
| Erythrocytes | 3 | 2016 | 219 | 0.220 |
Why?
|
| Dioxygenases | 3 | 2019 | 46 | 0.210 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 312 | 0.210 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 2 | 2021 | 6 | 0.200 |
Why?
|
| Young Adult | 9 | 2025 | 9052 | 0.200 |
Why?
|
| Recombinant Proteins | 2 | 2024 | 1399 | 0.200 |
Why?
|
| DNA Methylation | 2 | 2019 | 1006 | 0.200 |
Why?
|
| Amino Acid Sequence | 9 | 2011 | 2714 | 0.190 |
Why?
|
| Genes, Dominant | 2 | 2018 | 245 | 0.190 |
Why?
|
| Cell Nucleus | 1 | 2024 | 676 | 0.190 |
Why?
|
| Bone Marrow Cells | 4 | 2018 | 264 | 0.190 |
Why?
|
| Alternative Splicing | 5 | 2008 | 352 | 0.190 |
Why?
|
| Colony-Forming Units Assay | 3 | 2020 | 69 | 0.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2020 | 1203 | 0.190 |
Why?
|
| Hemoglobins | 1 | 2023 | 311 | 0.190 |
Why?
|
| Nestin | 2 | 2018 | 17 | 0.180 |
Why?
|
| Introns | 4 | 1999 | 300 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2016 | 412 | 0.180 |
Why?
|
| Gene Knock-In Techniques | 1 | 2021 | 123 | 0.170 |
Why?
|
| Cells, Cultured | 8 | 2019 | 3056 | 0.170 |
Why?
|
| Genetic Linkage | 2 | 2018 | 453 | 0.170 |
Why?
|
| Adenosine Triphosphate | 2 | 2024 | 282 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 4 | 2017 | 1065 | 0.160 |
Why?
|
| Genetic Markers | 3 | 2006 | 603 | 0.160 |
Why?
|
| Membrane Proteins | 2 | 2019 | 1527 | 0.160 |
Why?
|
| Transaminases | 1 | 2019 | 32 | 0.160 |
Why?
|
| Genetics, Medical | 1 | 2000 | 118 | 0.160 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 1999 | 9 | 0.160 |
Why?
|
| Hematopoietic System | 1 | 1999 | 7 | 0.160 |
Why?
|
| Transcription, Genetic | 1 | 2024 | 1699 | 0.160 |
Why?
|
| Reticulin | 1 | 2018 | 8 | 0.160 |
Why?
|
| Sympathomimetics | 1 | 2018 | 12 | 0.160 |
Why?
|
| Acetanilides | 1 | 2018 | 6 | 0.160 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 44 | 0.150 |
Why?
|
| Microvessels | 2 | 2016 | 57 | 0.150 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2018 | 8 | 0.150 |
Why?
|
| Haplotypes | 3 | 2009 | 522 | 0.150 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 147 | 0.150 |
Why?
|
| Disease Progression | 3 | 2015 | 2067 | 0.150 |
Why?
|
| Cell Line | 6 | 2017 | 2756 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 1290 | 0.150 |
Why?
|
| Prognosis | 4 | 2025 | 4644 | 0.150 |
Why?
|
| Cytokines | 5 | 2011 | 1288 | 0.140 |
Why?
|
| Oligonucleotides | 1 | 2018 | 90 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 1005 | 0.140 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2017 | 30 | 0.140 |
Why?
|
| Haploinsufficiency | 1 | 2019 | 258 | 0.140 |
Why?
|
| Hemostasis | 2 | 2007 | 70 | 0.140 |
Why?
|
| Sequence Deletion | 1 | 1999 | 525 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 314 | 0.140 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 64 | 0.140 |
Why?
|
| Platelet Count | 3 | 2013 | 136 | 0.140 |
Why?
|
| Erythroid Precursor Cells | 2 | 2008 | 24 | 0.140 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2016 | 21 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 553 | 0.130 |
Why?
|
| DNA, Complementary | 3 | 2008 | 462 | 0.130 |
Why?
|
| Tissue Donors | 1 | 2020 | 494 | 0.130 |
Why?
|
| Crosses, Genetic | 2 | 2014 | 163 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 282 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 3 | 2016 | 240 | 0.130 |
Why?
|
| Stem Cells | 2 | 2018 | 707 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 4 | 2011 | 1586 | 0.130 |
Why?
|
| Immunoglobulin M | 1 | 2017 | 212 | 0.130 |
Why?
|
| RNA Splicing | 1 | 1998 | 226 | 0.130 |
Why?
|
| Phosphoproteins | 2 | 2010 | 418 | 0.130 |
Why?
|
| Hodgkin Disease | 1 | 2019 | 292 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2000 | 443 | 0.130 |
Why?
|
| Integrases | 2 | 2007 | 159 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 96 | 0.130 |
Why?
|
| Trans-Activators | 2 | 1999 | 798 | 0.130 |
Why?
|
| Carcinogenesis | 1 | 2019 | 333 | 0.130 |
Why?
|
| Milk Proteins | 1 | 1996 | 92 | 0.130 |
Why?
|
| Antibodies | 1 | 2017 | 374 | 0.120 |
Why?
|
| Heparin | 1 | 2017 | 224 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2007 | 107 | 0.120 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 384 | 0.120 |
Why?
|
| Recombination, Genetic | 2 | 2007 | 447 | 0.120 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1995 | 13 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2016 | 219 | 0.120 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1996 | 137 | 0.120 |
Why?
|
| Autoimmune Diseases | 1 | 1997 | 251 | 0.120 |
Why?
|
| Genes, myc | 1 | 1995 | 99 | 0.120 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2014 | 15 | 0.120 |
Why?
|
| Survival Analysis | 2 | 2014 | 1506 | 0.120 |
Why?
|
| Transplantation Chimera | 1 | 2014 | 37 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2014 | 617 | 0.120 |
Why?
|
| Leukocytes | 3 | 2018 | 211 | 0.120 |
Why?
|
| Antigens, Ly | 1 | 2014 | 34 | 0.120 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2016 | 117 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 57 | 0.110 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2014 | 60 | 0.110 |
Why?
|
| Enzyme Activation | 3 | 2015 | 627 | 0.110 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 816 | 0.110 |
Why?
|
| Isoantigens | 2 | 2005 | 18 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2014 | 117 | 0.110 |
Why?
|
| Chronic Disease | 4 | 2009 | 1197 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2011 | 772 | 0.110 |
Why?
|
| DNA Repair | 1 | 2017 | 585 | 0.110 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 777 | 0.110 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 308 | 0.110 |
Why?
|
| Sympathetic Nervous System | 1 | 2014 | 66 | 0.110 |
Why?
|
| Membrane Glycoproteins | 3 | 2010 | 411 | 0.110 |
Why?
|
| Genes, abl | 1 | 2013 | 7 | 0.110 |
Why?
|
| Nerve Fibers | 1 | 2014 | 73 | 0.110 |
Why?
|
| Protein Binding | 4 | 2015 | 1756 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2014 | 329 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 2 | 2005 | 271 | 0.110 |
Why?
|
| Dasatinib | 1 | 2013 | 40 | 0.110 |
Why?
|
| Receptors, Colony-Stimulating Factor | 1 | 1993 | 2 | 0.110 |
Why?
|
| GPI-Linked Proteins | 2 | 2005 | 101 | 0.110 |
Why?
|
| Transduction, Genetic | 2 | 2018 | 289 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2014 | 398 | 0.110 |
Why?
|
| Liver | 4 | 2025 | 1748 | 0.110 |
Why?
|
| Tamoxifen | 1 | 2014 | 363 | 0.100 |
Why?
|
| Models, Genetic | 3 | 2005 | 760 | 0.100 |
Why?
|
| COS Cells | 3 | 2015 | 274 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 1993 | 112 | 0.100 |
Why?
|
| Cell Division | 3 | 2011 | 781 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 3348 | 0.100 |
Why?
|
| Dendritic Cells | 2 | 2006 | 414 | 0.100 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2009 | 40 | 0.100 |
Why?
|
| Genes, Reporter | 2 | 2004 | 381 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 767 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2014 | 505 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2014 | 1102 | 0.090 |
Why?
|
| Translocation, Genetic | 1 | 2013 | 358 | 0.090 |
Why?
|
| Guanylate Cyclase | 1 | 2011 | 38 | 0.090 |
Why?
|
| DNA | 5 | 2008 | 1608 | 0.090 |
Why?
|
| Biomarkers | 2 | 2014 | 3091 | 0.090 |
Why?
|
| Inflammation | 1 | 2018 | 1446 | 0.090 |
Why?
|
| DNA Damage | 1 | 2014 | 513 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 463 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 81 | 0.090 |
Why?
|
| Hematologic Diseases | 1 | 2012 | 79 | 0.090 |
Why?
|
| Platelet Activation | 1 | 2011 | 71 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2019 | 923 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 458 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 121 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2014 | 470 | 0.090 |
Why?
|
| Child | 7 | 2025 | 24422 | 0.090 |
Why?
|
| Platelet Aggregation | 2 | 2007 | 121 | 0.090 |
Why?
|
| Lymphatic Vessels | 1 | 2010 | 37 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2010 | 2637 | 0.080 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 70 | 0.080 |
Why?
|
| Gene Expression | 1 | 2014 | 1560 | 0.080 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2009 | 11 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2016 | 14027 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2025 | 733 | 0.080 |
Why?
|
| DNA Primers | 2 | 2004 | 657 | 0.080 |
Why?
|
| Italy | 1 | 2009 | 100 | 0.080 |
Why?
|
| Sequence Analysis | 2 | 1999 | 54 | 0.080 |
Why?
|
| Cell Separation | 1 | 2010 | 229 | 0.080 |
Why?
|
| Transfection | 2 | 2004 | 1069 | 0.080 |
Why?
|
| STAT Transcription Factors | 1 | 2009 | 23 | 0.080 |
Why?
|
| Debrisoquin | 1 | 1988 | 1 | 0.080 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2009 | 93 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 389 | 0.080 |
Why?
|
| Receptors, Leptin | 3 | 1998 | 40 | 0.080 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 50 | 0.080 |
Why?
|
| Isoquinolines | 1 | 1988 | 40 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2011 | 376 | 0.070 |
Why?
|
| Poland | 1 | 2008 | 48 | 0.070 |
Why?
|
| Talin | 1 | 2007 | 9 | 0.070 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2007 | 8 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 388 | 0.070 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2007 | 7 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1711 | 0.070 |
Why?
|
| Apoptosis | 3 | 2014 | 1806 | 0.070 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1988 | 135 | 0.070 |
Why?
|
| Binding Sites | 2 | 2024 | 1303 | 0.070 |
Why?
|
| Integrins | 1 | 2007 | 99 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2007 | 208 | 0.070 |
Why?
|
| Infant | 2 | 2015 | 12515 | 0.070 |
Why?
|
| Family Health | 1 | 2008 | 259 | 0.070 |
Why?
|
| Whole-Body Irradiation | 2 | 2018 | 64 | 0.070 |
Why?
|
| Stomach Diseases | 1 | 2007 | 56 | 0.070 |
Why?
|
| Polyps | 1 | 2007 | 44 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2007 | 86 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2008 | 440 | 0.070 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 572 | 0.070 |
Why?
|
| Organ Specificity | 3 | 2011 | 428 | 0.070 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2006 | 93 | 0.070 |
Why?
|
| Transcription Factors | 2 | 1999 | 2593 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 634 | 0.060 |
Why?
|
| Embryo, Mammalian | 2 | 2010 | 460 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2019 | 18 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2019 | 23 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1999 | 144 | 0.060 |
Why?
|
| Glycosylation | 1 | 2025 | 125 | 0.060 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2005 | 96 | 0.060 |
Why?
|
| Proteins | 2 | 2003 | 1036 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2025 | 319 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 461 | 0.060 |
Why?
|
| CD4 Antigens | 1 | 2004 | 57 | 0.060 |
Why?
|
| Protein Sorting Signals | 1 | 2004 | 39 | 0.060 |
Why?
|
| CD40 Antigens | 1 | 2004 | 26 | 0.060 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 69 | 0.060 |
Why?
|
| Dipeptides | 1 | 2004 | 57 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 167 | 0.050 |
Why?
|
| Thermodynamics | 1 | 2024 | 144 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 1984 | 82 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2025 | 210 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2016 | 4817 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 156 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 5176 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2004 | 144 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2004 | 212 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2004 | 206 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2004 | 403 | 0.050 |
Why?
|
| Plasmids | 1 | 2004 | 513 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2025 | 194 | 0.050 |
Why?
|
| NFI Transcription Factors | 1 | 2003 | 50 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 581 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2025 | 16353 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 656 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2002 | 56 | 0.050 |
Why?
|
| Cell Movement | 1 | 2006 | 847 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2009 | 3300 | 0.050 |
Why?
|
| Cell Survival | 1 | 2004 | 813 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 432 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2004 | 699 | 0.050 |
Why?
|
| Genotype | 1 | 2008 | 2565 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2002 | 391 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 1265 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2021 | 2311 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 824 | 0.050 |
Why?
|
| Tissue Scaffolds | 1 | 2021 | 80 | 0.040 |
Why?
|
| Sepsis | 1 | 2005 | 481 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2024 | 1079 | 0.040 |
Why?
|
| Peptides | 1 | 2004 | 811 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2022 | 264 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2021 | 149 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1697 | 0.040 |
Why?
|
| 5' Untranslated Regions | 1 | 2000 | 58 | 0.040 |
Why?
|
| Models, Biological | 1 | 2005 | 1460 | 0.040 |
Why?
|
| Ferritins | 1 | 2000 | 98 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2000 | 181 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2025 | 880 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 658 | 0.040 |
Why?
|
| Japan | 1 | 1999 | 133 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2015 | 1631 | 0.040 |
Why?
|
| Finland | 1 | 2019 | 42 | 0.040 |
Why?
|
| De Lange Syndrome | 1 | 1999 | 44 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 2 | 2011 | 30 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6153 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2019 | 45 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 101 | 0.040 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2019 | 77 | 0.040 |
Why?
|
| Immunoglobulin D | 1 | 1978 | 6 | 0.040 |
Why?
|
| Telomere | 1 | 2020 | 214 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 376 | 0.040 |
Why?
|
| Bioreactors | 1 | 2018 | 38 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 667 | 0.040 |
Why?
|
| Biomimetics | 1 | 2018 | 16 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2020 | 219 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1978 | 52 | 0.040 |
Why?
|
| K562 Cells | 1 | 2018 | 95 | 0.040 |
Why?
|
| Phthalazines | 1 | 2017 | 13 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 186 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 557 | 0.040 |
Why?
|
| Ligands | 1 | 1999 | 539 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 281 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 228 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1997 | 155 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 173 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 238 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 281 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 1997 | 300 | 0.030 |
Why?
|
| Glycoproteins | 1 | 1999 | 370 | 0.030 |
Why?
|
| Fibrosis | 1 | 2018 | 436 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 429 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2018 | 180 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 1996 | 35 | 0.030 |
Why?
|
| Hypothalamus | 1 | 1998 | 213 | 0.030 |
Why?
|
| Immune Sera | 1 | 1996 | 95 | 0.030 |
Why?
|
| Radiation Injuries, Experimental | 1 | 1996 | 22 | 0.030 |
Why?
|
| Peroxidase | 1 | 2016 | 69 | 0.030 |
Why?
|
| Piperazines | 1 | 2017 | 241 | 0.030 |
Why?
|
| Leptin | 1 | 1997 | 214 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 361 | 0.030 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 1995 | 3 | 0.030 |
Why?
|
| GATA1 Transcription Factor | 1 | 1995 | 9 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1999 | 1078 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 171 | 0.030 |
Why?
|
| Rabbits | 1 | 1996 | 718 | 0.030 |
Why?
|
| Genomics | 1 | 2022 | 1499 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 262 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 130 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 237 | 0.030 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2014 | 6 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 311 | 0.030 |
Why?
|
| Capillaries | 1 | 2014 | 66 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 1999 | 813 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2015 | 104 | 0.030 |
Why?
|
| Photons | 1 | 2014 | 48 | 0.030 |
Why?
|
| Rats | 2 | 1998 | 3727 | 0.030 |
Why?
|
| Microcirculation | 1 | 2014 | 96 | 0.030 |
Why?
|
| Growth Inhibitors | 1 | 1994 | 38 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2016 | 474 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2000 | 1755 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 678 | 0.030 |
Why?
|
| Schwann Cells | 1 | 2014 | 57 | 0.030 |
Why?
|
| Lymphokines | 1 | 1994 | 67 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1994 | 100 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2014 | 89 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2014 | 125 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2014 | 151 | 0.030 |
Why?
|
| Testis | 1 | 1996 | 410 | 0.030 |
Why?
|
| Optics and Photonics | 1 | 2014 | 139 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 330 | 0.030 |
Why?
|
| Arteries | 1 | 2014 | 225 | 0.030 |
Why?
|
| Chemokines | 1 | 2013 | 133 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 320 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1993 | 140 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2014 | 458 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2014 | 210 | 0.030 |
Why?
|
| Mitoxantrone | 1 | 2012 | 26 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 163 | 0.020 |
Why?
|
| Erythroblasts | 1 | 2012 | 5 | 0.020 |
Why?
|
| Etoposide | 1 | 2012 | 115 | 0.020 |
Why?
|
| Anemia, Hemolytic, Congenital | 1 | 2012 | 3 | 0.020 |
Why?
|
| Multigene Family | 1 | 1993 | 299 | 0.020 |
Why?
|
| Genes, Synthetic | 1 | 2012 | 12 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2012 | 15 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2012 | 11 | 0.020 |
Why?
|
| Recombinases | 1 | 2012 | 22 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 294 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2012 | 76 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 1994 | 379 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 1994 | 420 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 897 | 0.020 |
Why?
|
| Leukopenia | 1 | 2012 | 45 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 889 | 0.020 |
Why?
|
| Soluble Guanylyl Cyclase | 1 | 2011 | 6 | 0.020 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2011 | 9 | 0.020 |
Why?
|
| Polyploidy | 1 | 2011 | 15 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2011 | 95 | 0.020 |
Why?
|
| Protein Folding | 1 | 2012 | 215 | 0.020 |
Why?
|
| Europe | 1 | 2012 | 354 | 0.020 |
Why?
|
| Leukocytosis | 1 | 2011 | 46 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1360 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 145 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2011 | 396 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 10315 | 0.020 |
Why?
|
| Endothelium, Lymphatic | 1 | 2010 | 10 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2012 | 214 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2011 | 296 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 471 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 359 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2010 | 104 | 0.020 |
Why?
|
| World Health Organization | 1 | 2009 | 105 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1172 | 0.020 |
Why?
|
| Kidney | 1 | 1996 | 1368 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 89 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 121 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2057 | 0.020 |
Why?
|
| Integrin alpha2beta1 | 1 | 2007 | 8 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2011 | 493 | 0.020 |
Why?
|
| Leukemia, Lymphoid | 1 | 1988 | 109 | 0.020 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1988 | 48 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1988 | 52 | 0.020 |
Why?
|
| Integrin beta3 | 1 | 2007 | 27 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2008 | 62 | 0.020 |
Why?
|
| Integrin beta1 | 1 | 2007 | 56 | 0.020 |
Why?
|
| Reference Standards | 1 | 2008 | 236 | 0.020 |
Why?
|
| Bleeding Time | 1 | 2007 | 8 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2007 | 62 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1897 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2007 | 77 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2008 | 229 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 527 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2013 | 1004 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2010 | 526 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 691 | 0.020 |
Why?
|
| Calcium | 1 | 2011 | 1102 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2006 | 28 | 0.020 |
Why?
|
| Heterozygote | 1 | 1988 | 671 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 95 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 111 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1693 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2006 | 246 | 0.020 |
Why?
|
| Chemokine CCL22 | 1 | 2004 | 6 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2006 | 724 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 2004 | 28 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 12392 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2004 | 58 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 335 | 0.010 |
Why?
|
| Brain | 1 | 1996 | 2999 | 0.010 |
Why?
|
| CD40 Ligand | 1 | 2004 | 64 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 1099 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2004 | 116 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 165 | 0.010 |
Why?
|
| Chickens | 1 | 1984 | 636 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1984 | 232 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 1691 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 207 | 0.010 |
Why?
|
| Species Specificity | 1 | 1984 | 550 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 1629 | 0.010 |
Why?
|
| Monocytes | 1 | 2004 | 345 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2893 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 459 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 1496 | 0.010 |
Why?
|
| Swine | 1 | 1984 | 1210 | 0.010 |
Why?
|
| Goosecoid Protein | 1 | 1999 | 4 | 0.010 |
Why?
|
| Cosmids | 1 | 1999 | 48 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1999 | 95 | 0.010 |
Why?
|
| Radioallergosorbent Test | 1 | 1978 | 7 | 0.010 |
Why?
|
| Mitochondria | 1 | 1984 | 680 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 985 | 0.010 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 1978 | 24 | 0.010 |
Why?
|
| Myocardium | 1 | 1984 | 1020 | 0.010 |
Why?
|
| Supraoptic Nucleus | 1 | 1998 | 4 | 0.010 |
Why?
|
| Vasopressins | 1 | 1998 | 43 | 0.010 |
Why?
|
| Receptors, Somatostatin | 1 | 1998 | 54 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1978 | 160 | 0.010 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 1998 | 39 | 0.010 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 1998 | 54 | 0.010 |
Why?
|
| Oxytocin | 1 | 1998 | 68 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 459 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 1999 | 548 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1998 | 1243 | 0.010 |
Why?
|
| Sex Factors | 1 | 1978 | 1289 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1994 | 13 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1994 | 28 | 0.010 |
Why?
|
| Hypergammaglobulinemia | 1 | 1994 | 11 | 0.010 |
Why?
|
| Blood | 1 | 1994 | 104 | 0.010 |
Why?
|
| Epithelium | 1 | 1994 | 364 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 1998 | 702 | 0.010 |
Why?
|
| Age Factors | 1 | 1978 | 2823 | 0.010 |
Why?
|
| Asthma | 1 | 1978 | 756 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1994 | 909 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 1988 | 30 | 0.000 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 1988 | 31 | 0.000 |
Why?
|
| Neurons | 1 | 1998 | 1932 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1994 | 1726 | 0.000 |
Why?
|